GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AC Immune SA (NAS:ACIU) » Definitions » Float Percentage Of Total Shares Outstanding

AC Immune (AC Immune) Float Percentage Of Total Shares Outstanding : 53.57% (As of Jun. 01, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AC Immune Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AC Immune's float shares is 52.99 Mil. AC Immune's total shares outstanding is 98.90 Mil. AC Immune's float percentage of total shares outstanding is 53.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AC Immune's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AC Immune's Institutional Ownership is 3.43%.

AC Immune Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

AC Immune's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=52.99/98.90
=53.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AC Immune (AC Immune) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AC Immune SA (NAS:ACIU) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
CELC CMPX NUVB XERS YMAB DRTS ARQT ZURA EPIX HUMA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
IMR:Germany IMR:Germany
Address
EPFL Innovation Park, Building B, Lausanne, CHE, 1015
Website
https://www.acimmune.com
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.